Psychiatry and Neurology, Neurology · Ann Arbor, MI
NPI
1508879206
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4260 Plymouth Rd
Ann Arbor, MI, 48109
Phone (734) 764-6831
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
558 services
Medicare patients, 2024
197
Average age 73
Drug cost, 2024
$910K
2,692 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Praveen Dayalu was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 106 times for 82 patients. In total Praveen Dayalu billed 558 services in 31 codes, and Medicare paid $34K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 106 | 82 | $11.87 | $1,258 |
| 99214 Office E&M - Established | Office | 64 | 50 | $67.72 | $4,334 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 60 | 41 | $11.44 | $687 |
| 99215 Office E&M - Established | Office | 31 | 28 | $105.65 | $3,275 |
| 99213 Office E&M - Established | Facility | 28 | 22 | $45.16 | $1,264 |
| 99215 Office E&M - Established | Facility | 27 | 21 | $103.90 | $2,805 |
| 64612 Musculoskeletal | Facility | 27 | 12 | $124.72 | $3,367 |
| 99213 Office E&M - Established | Office | 22 | 21 | $47.50 | $1,045 |
| 99214 Office E&M - Established | Facility | 21 | 16 | $72.53 | $1,523 |
| 99205 Office E&M - New | Office | 18 | 18 | $119.88 | $2,158 |
By year: 2022 $42K for 537 services; 2023 $38K for 507 services; 2024 $34K for 558 services.
Medicare prescription drug claims, 2024
In 2024, the drug Praveen Dayalu prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 697 prescriptions and refills. In total Praveen Dayalu wrote 2,692 Medicare prescriptions that cost $910K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 697 | 1,700 | 184 | $47K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 227 | 555 | 69 | $18K |
| Mirtazapine Generic | 117 | 303 | 42 | $2,410 |
| Entacapone Generic | 113 | 227 | 29 | $25K |
| Amantadine Amantadine Hcl | 95 | 230 | 29 | $9,558 |
| Propranolol Hcl Er Propranolol Hcl | 91 | 205 | 24 | $4,332 |
| Primidone Generic | 90 | 229 | 23 | $2,579 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 89 | 225 | 31 | $1,550 |
| Donepezil Hcl Generic | 81 | 235 | 29 | $1,361 |
| Gabapentin Generic | 61 | 148 | 27 | $1,160 |
| Rivastigmine Rivastigmine Tartrate | 60 | 109 | 17 | $3,962 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 54 | 129 | 15 | $1,447 |
| Sertraline Hcl Generic | 52 | 150 | 17 | $698 |
| Rivastigmine Generic | 48 | 88 | 13 | $13K |
| Midodrine Hcl Generic | 45 | 119 | 16 | $2,673 |
Brand drugs: 184 claims; generic drugs: 2,508 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Praveen Dayalu $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.